Panacea Biotec: The Board of Directors has at its meeting held today, i.e. Saturday, November 14, 2026, inter-alia,…
Panacea Biotec (PANACEABIO) filed a disclosure titled "The Board of Directors has at its meeting held today, i.e. Saturday, November 14, 2026, inter-alia, considered and approved the Standalone and Consolidated". The company is valued at about ₹2,214 crore.
What happened
Panacea Biotec (PANACEABIO) filed a disclosure with the exchanges on 14 November 2026 at 08:25 PM titled "The Board of Directors has at its meeting held today, i.e. Saturday, November 14, 2026, inter-alia, considered and approved the Standalone and Consolidated".
Company snapshot
Panacea Biotec is a small-cap company, with a market value of about ₹2,214 crore.
The stock last traded at ₹361.5, against a 52-week range of ₹292.4–₹647 (44.1% below the high).
Before this filing the shares had moved +3.4% over the month and −12.7% over three months. Average daily turnover over the last 20 sessions was about ₹1.78 crore.
Promoters held 72.48% at the end of Q1 FY27. Foreign institutions owned 2.31% and domestic institutions 2.25%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 167 | 4.1 | 0.66 |
| Q2 FY26 | 141 | -13.9 | -2.27 |
| Q3 FY26 | 165 | 4 | 0.65 |
| Q4 FY26 | 167 | 0.5 | 0.08 |
| Q1 FY27 | 200 | 2.3 | 0.38 |
What history shows
BCEIE has no earlier approval filing from this company on record since May 2026.
Market-wide, 1,630 approval filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 48% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- 14 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.